| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Over the last 12 months, insiders at bioAffinity Technologies, Inc. have bought $0 and sold $0 worth of bioAffinity Technologies, Inc. stock.
On average, over the past 5 years, insiders at bioAffinity Technologies, Inc. have bought $99,997 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,448 shares for transaction amount of $0 was made by Edwards James Michael (Chief Financial Officer) on 2022‑09‑01.
| 2022-09-01 | Edwards James Michael | Chief Financial Officer | 2,448 – | $0 | $0 | -77.35% | ||
| 2022-08-31 | Rubin Gary D | director | 32,652 0.5281% | $3.06 | $99,997 | -77.35% | ||
| 2022-08-31 | GIRGENTI STEVEN | Executive Chairman | 40,916 – | $0 | $0 | -77.35% | ||
| 2022-08-31 | KNIGHT PETER S | director | 8,163 – | $0 | $0 | -77.35% | ||
| 2022-08-31 | Zannes Maria | President, CEO | 16,326 – | $0 | $0 | -77.35% |
| Rubin Gary D | director | 1584144 25.2129% | $5.05M | 1 | 0 | <0.0001% |
| GIRGENTI STEVEN | Executive Chairman | 861099 13.7051% | $2.75M | 1 | 0 | |
| Edwards James Michael | Chief Financial Officer | 30323 0.4826% | $96,730.37 | 1 | 0 | |
| KNIGHT PETER S | director | 22448 0.3573% | $71,609.12 | 1 | 0 | |
| Zannes Maria | President, CEO | 19897 0.3167% | $63,471.43 | 1 | 0 |
$13,470,814 | 657 | -0.42% | $35.64M | |
$78,162,120 | 207 | 10.26% | $241.09M | |
$26,663,659 | 7 | -12.13% | $56.02B | |
$66,999 | 2 | -47.60% | $5.87M | |
bioAffinity Technologies, Inc. (BIAF) | $99,997 | 1 | -77.35% | $20.04M |
| Increased Positions | 7 | +36.84% | 75,222 | +24.79% |
| Decreased Positions | 9 | -47.37% | 298,408 | -98.35% |
| New Positions | 4 | New | 65,903 | New |
| Sold Out Positions | 7 | Sold Out | 271,762 | Sold Out |
| Total Postitions | 17 | -10.53% | 80,213 | -73.56% |
| Sabby Management, Llc | $296.00 | 6.07% | 242,757 | +242,757 | New | 2025-09-30 |
| Ifp Advisors, Inc | $32.00 | 0.65% | 25,833 | +25,000 | +3,001.2% | 2025-09-30 |
| Scientech Research Llc | $20.00 | 0.42% | 16,583 | +16,583 | New | 2025-09-30 |
| Vanguard Group Inc | $13.00 | 0.26% | 10,429 | +9,074 | +669.67% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $3.00 | 0.06% | 2,499 | +2,395 | +2,302.89% | 2025-09-30 |
| Allworth Financial Lp | $2.00 | 0.05% | 1,791 | 0 | 0% | 2025-09-30 |
| Sheaff Brock Investment Advisors, Llc | $2.00 | 0.05% | 1,791 | +248 | +16.07% | 2025-03-31 |
| Bank Of America Corp /De/ | $2.00 | 0.04% | 1,684 | +1,677 | +23,957.14% | 2025-09-30 |
| Ubs Group Ag | $0 | <0.01% | 143 | +142 | +14,200% | 2025-09-30 |
| Citigroup Inc | $0 | <0.01% | 75 | +26 | +53.06% | 2025-09-30 |